SERDA Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

SERDA Therapeutics General Information

Description

Developer of a surgical treatment designed to facilitate therapeutic debridement of burn injuries and chronic ulcers. The company offers a prescription product containing a proteolytic enzyme that selectively digests and removes necrotic tissue and eschar from wounds, enabling doctors to gain access to fast and effective wound healing with ease of use, high stability, and low-to-moderate irritation potential, improving patient outcomes in the treatment of burn injuries and chronic ulcers.

Contact Information

Website
www.serda-therapeutics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Paasheuvelweg 25
  • 1105 BP Amsterdam
  • Netherlands
+31 020
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Corporate Office
  • Paasheuvelweg 25
  • 1105 BP Amsterdam
  • Netherlands
+31 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SERDA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 16-Jul-2026 Completed Clinical Trials - Phase 1
5. Early Stage VC (Series 1) 03-Jun-2024 Completed Clinical Trials - Phase 1
4. Seed Round 10-Oct-2022 Completed Clinical Trials - Phase 1
3. Seed Round 27-Apr-2021 Completed Pre-Clinical Trials
2. Seed Round 17-Nov-2020 Completed Startup
1. Joint Venture 01-Nov-2020 Completed Startup
To view SERDA Therapeutics’s complete valuation and funding history, request access »

SERDA Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
NLC Health Ventures Venture Capital Majority
To view SERDA Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

SERDA Therapeutics FAQs

  • When was SERDA Therapeutics founded?

    SERDA Therapeutics was founded in 2020.

  • Where is SERDA Therapeutics headquartered?

    SERDA Therapeutics is headquartered in Amsterdam, Netherlands.

  • What industry is SERDA Therapeutics in?

    SERDA Therapeutics’s primary industry is Drug Delivery.

  • Is SERDA Therapeutics a private or public company?

    SERDA Therapeutics is a Private company.

  • What is SERDA Therapeutics’s current revenue?

    The current revenue for SERDA Therapeutics is .

  • How much funding has SERDA Therapeutics raised over time?

    SERDA Therapeutics has raised $2.52M.

  • Who are SERDA Therapeutics’s investors?

    NLC Health Ventures has invested in SERDA Therapeutics.

  • When was SERDA Therapeutics acquired?

    SERDA Therapeutics was acquired on 16-Jul-2026.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process